Immuno-Biological Laboratories, Innogenetics NV, Takeda deal

INNX granted Immuno-Biological a non-exclusive license to IP covering the diagnostic and research use of beta-amyloid antibodies. INNX will receive a license fee and is eligible for royalties. The IP...